Last, we performed an in vivo tumor growth inhibition study using the MC38 colorectal adenocarcinoma model, which is known to respond to IL-7 treatment (26), to compare the antitumor activity of IL-7 versus IL-7–CBD (fig. This evidence concerns the gene IL7 and colorectal adenocarcinoma.